{"id":38012,"date":"2025-07-28T14:11:15","date_gmt":"2025-07-28T06:11:15","guid":{"rendered":"https:\/\/flcube.com\/?p=38012"},"modified":"2025-07-28T14:11:16","modified_gmt":"2025-07-28T06:11:16","slug":"sansure-biotechs-gene-polymorphism-detection-kits-receive-nmpa-class-iii-ivd-certification","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=38012","title":{"rendered":"Sansure Biotech’s Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification"},"content":{"rendered":"\n

China-based Sansure Biotech Inc. (SHA: 688289<\/a>) announced on July 28, 2025, that it has received Class III In Vitro Diagnostic (IVD) Medical Device Registration Certificates from China’s National Medical Products Administration (NMPA) for two of its gene polymorphism detection kits. The certificates are valid until July 23, 2030. The approved products are the Human ADRB1 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method) and the Human AGTR1 and CYP2C9 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method).<\/p>\n\n\n\n

Product Applications<\/strong>
Both kits are designed to detect polymorphisms in key gene loci\u2014ADRB1, AGTR1, and CYP2C9*3\u2014which are associated with hypertension. These tests provide a genetic basis for personalized treatment of patients using medications such as \u03b2-blockers and angiotensin II receptor antagonists.<\/p>\n\n\n\n

Company Expansion<\/strong>
Over the past year, Sansure Biotech has launched eight related products, establishing a comprehensive pharmacogenomics testing portfolio that covers anticoagulation, hypertension, and hyperlipidemia. The company stated it will continue to expand its presence in this field.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

China-based Sansure Biotech Inc. (SHA: 688289) announced on July 28, 2025, that it has received…<\/p>\n","protected":false},"author":1,"featured_media":38013,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[69,15,259,906],"class_list":["post-38012","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-medical-device","tag-cvd","tag-product-approvals","tag-sansure-biotech","tag-sha-688289"],"yoast_head":"\nSansure Biotech's Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Sansure Biotech Inc. (SHA: 688289) announced on July 28, 2025, that it has received Class III In Vitro Diagnostic (IVD) Medical Device Registration Certificates from China's National Medical Products Administration (NMPA) for two of its gene polymorphism detection kits. The certificates are valid until July 23, 2030. The approved products are the Human ADRB1 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method) and the Human AGTR1 and CYP2C9 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=38012\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sansure Biotech's Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification\" \/>\n<meta property=\"og:description\" content=\"China-based Sansure Biotech Inc. (SHA: 688289) announced on July 28, 2025, that it has received Class III In Vitro Diagnostic (IVD) Medical Device Registration Certificates from China's National Medical Products Administration (NMPA) for two of its gene polymorphism detection kits. The certificates are valid until July 23, 2030. The approved products are the Human ADRB1 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method) and the Human AGTR1 and CYP2C9 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=38012\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-28T06:11:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-28T06:11:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2807.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38012#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38012\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Sansure Biotech’s Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification\",\"datePublished\":\"2025-07-28T06:11:15+00:00\",\"dateModified\":\"2025-07-28T06:11:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38012\"},\"wordCount\":175,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38012#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2807.webp\",\"keywords\":[\"CVD\",\"Product approvals\",\"Sansure Biotech\",\"SHA: 688289\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38012#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38012\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=38012\",\"name\":\"Sansure Biotech's Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38012#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38012#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2807.webp\",\"datePublished\":\"2025-07-28T06:11:15+00:00\",\"dateModified\":\"2025-07-28T06:11:16+00:00\",\"description\":\"China-based Sansure Biotech Inc. (SHA: 688289) announced on July 28, 2025, that it has received Class III In Vitro Diagnostic (IVD) Medical Device Registration Certificates from China's National Medical Products Administration (NMPA) for two of its gene polymorphism detection kits. The certificates are valid until July 23, 2030. The approved products are the Human ADRB1 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method) and the Human AGTR1 and CYP2C9 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38012#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38012\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38012#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2807.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2807.webp\",\"width\":1080,\"height\":608,\"caption\":\"Sansure Biotech's Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38012#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sansure Biotech’s Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sansure Biotech's Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification - Insight, China's Pharmaceutical Industry","description":"China-based Sansure Biotech Inc. (SHA: 688289) announced on July 28, 2025, that it has received Class III In Vitro Diagnostic (IVD) Medical Device Registration Certificates from China's National Medical Products Administration (NMPA) for two of its gene polymorphism detection kits. The certificates are valid until July 23, 2030. The approved products are the Human ADRB1 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method) and the Human AGTR1 and CYP2C9 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=38012","og_locale":"en_US","og_type":"article","og_title":"Sansure Biotech's Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification","og_description":"China-based Sansure Biotech Inc. (SHA: 688289) announced on July 28, 2025, that it has received Class III In Vitro Diagnostic (IVD) Medical Device Registration Certificates from China's National Medical Products Administration (NMPA) for two of its gene polymorphism detection kits. The certificates are valid until July 23, 2030. The approved products are the Human ADRB1 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method) and the Human AGTR1 and CYP2C9 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method).","og_url":"https:\/\/flcube.com\/?p=38012","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-07-28T06:11:15+00:00","article_modified_time":"2025-07-28T06:11:16+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2807.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=38012#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=38012"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Sansure Biotech’s Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification","datePublished":"2025-07-28T06:11:15+00:00","dateModified":"2025-07-28T06:11:16+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=38012"},"wordCount":175,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=38012#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2807.webp","keywords":["CVD","Product approvals","Sansure Biotech","SHA: 688289"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=38012#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=38012","url":"https:\/\/flcube.com\/?p=38012","name":"Sansure Biotech's Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=38012#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=38012#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2807.webp","datePublished":"2025-07-28T06:11:15+00:00","dateModified":"2025-07-28T06:11:16+00:00","description":"China-based Sansure Biotech Inc. (SHA: 688289) announced on July 28, 2025, that it has received Class III In Vitro Diagnostic (IVD) Medical Device Registration Certificates from China's National Medical Products Administration (NMPA) for two of its gene polymorphism detection kits. The certificates are valid until July 23, 2030. The approved products are the Human ADRB1 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method) and the Human AGTR1 and CYP2C9 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method).","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=38012#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=38012"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=38012#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2807.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2807.webp","width":1080,"height":608,"caption":"Sansure Biotech's Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=38012#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Sansure Biotech’s Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2807.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38012"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38012\/revisions"}],"predecessor-version":[{"id":38014,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38012\/revisions\/38014"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/38013"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}